Geodon (Generic: Ziprasidone) has been linked to diabetes and other blood sugar side effects such as hyperglycemia. Part of the new class of atypical antipsychotic drugs, Geodon is used to treat patients with schizophrenia. On Aug 31, 2004, the FDA & Pfizer, the manufacturer of Geodon, warned doctors about the risk of developing high blood sugar and diabetes. The FDA asked Pfizer to add a new warning to the Geodon label warning patients that Geodon can cause diabetes and other blood sugar disorders. In a recent study, atypical antipsychotics similar to Geodon were found to cause diabetes 50% more often than older antipsychotic drugs. The atypical antipsychotic class of drugs includes Geodon, Zyprexa, Risperdal, Seroquel, Abilify and Clozaril.
The FDA has become concerned about the possibility that Geodon / Ziprasidone and a number of other drugs might increase the possibility of a specific, potentially fatal heart-rhythm irregularity called torsade de pointes. The FDA did not approve Ziprasidone in 1998 because there was evidence that it could cause a lengthening of the so-called QT interval of the heartbeat, a change associated with torsade.
Additional Geodon side effects include: feeling unusually tired, nausea, constipation, dizziness, restlessness, diarrhea, rash, cough, runny nose, and abnormal muscle movements, including tremor, shuffling, and uncontrollable movements.
Legal Help For Victims Affected By Geodon
If you or a loved one took Geodon and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).